CO154 Are Biosimilars Equivalent to Originator Molecules in the Real-World? Assessments of Efficacy, Toxicity, and Tolerability of Infliximabs in Infliximab-Naïve Patients with Rheumatoid Arthritis
Abstract
Authors
C. Edgerton C. Adams A. Frick S.M. Helfgott K. Huston S. Milligan J.A. Singh N. Soloman